EDIT

EDIT R&D Expense Growth

-54.85%Fiscal year

Period ending:

EDIT FY R&D Growth (YoY)%
EDIT FY R&D Growth (YoY)310.66%-94.02%
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

EDIT r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Editas Medicine Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-54.8535%
12.1564%
1.5392%
22.7715%
-9.8034%
63.0539%
6.8877%
9.0129%
45.9468%
202.34%
271.4962%
219.0566%
0%

Compare r&d expense growth

All EDIT financial metrics · EDIT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.